Esperion Logo (primary).png
Real World Data Analysis Reveals Nearly Half of All Adults at High Risk for ASCVD and Eligible for a Statin Were Not On Any Statin
03. Juni 2022 12:30 ET | Esperion Therapeutics, Inc.
– Less than 1 in 10 were on any non-statin lipid lowering therapy – – Findings were shared at the National Lipid Association Scientific Sessions – ANN ARBOR, Mich., June 03, 2022 (GLOBE...
Esperion Logo (primary).png
Esperion Announces Five Abstracts Accepted for Presentation at the National Lipid Association Scientific Sessions
31. Mai 2022 08:00 ET | Esperion Therapeutics, Inc.
– Highlight of accepted abstracts includes new real-world data on lipid-lowering therapy usage, submitted in partnership with UT Southwestern – – Accepted abstracts showcase breadth of Esperion’s...
NLA LOGO - USE.png
National Lipid Association and Paradigm Medical Communications, LLC Announce Collaborative Partnership in Lipids Education
02. März 2021 09:00 ET | National Lipid Association
JACKSONVILLE, Fla. and ORANGEBURG, N.Y., March 02, 2021 (GLOBE NEWSWIRE) -- The National Lipid Association (NLA), the preeminent global authority on lipid disorders, and Paradigm Medical...
NLA LOGO - USE.png
National Lipid Association Releases Official Scientific Statement on Genetic Testing in Dyslipidemia
10. Juli 2020 12:30 ET | National Lipid Association
JACKSONVILLE, Fla., July 10, 2020 (GLOBE NEWSWIRE) -- The National Lipid Association (NLA) today announced the release of its official scientific statement on the use of genetic testing in the...
NLA LOGO - USE.png
Mount Sinai Icahn School of Medicine’s Dr. Robert S. Rosenson Receives Foundation of the National Lipid Association 2019 Clinician/Educator Award
18. Mai 2019 17:45 ET | National Lipid Association
MIAMI, May 18, 2019 (GLOBE NEWSWIRE) -- Robert S. Rosenson, MD, FACC, FACP, FAHA, FESC, FNLA, FACCP, Professor of Medicine and Director of Cardiometabolic Disorders at the Icahn School of Medicine...
NLA LOGO - USE.png
National Lipid Association (NLA) and the Foundation of the NLA Honors Renowned Cardiologist Dr. Vera Bittner with Distinguished Achievement Award
18. Mai 2019 17:45 ET | National Lipid Association
MIAMI, May 18, 2019 (GLOBE NEWSWIRE) -- The National Lipid Association (NLA) and the Foundation of the NLA have selected Vera A. Bittner, MD, MSPH, FNLA as the recipient of the 2019 W. Virgil Brown...
NLA LOGO - USE.png
National Lipid Association Announces Designation for Experts in Clinical Lipidology
17. Mai 2019 16:00 ET | National Lipid Association
MIAMI, Fla., May 17, 2019 (GLOBE NEWSWIRE) -- With the Centers for Disease Control and Prevention (CDC) indicating more than 95 million adults age 20 or older have total cholesterol (blood fat)...
NLA LOGO - USE.png
Statin Use Survey Among the First to Highlight Importance of Adverse Patient Experiences in Discontinuing Medication Use
17. Mai 2019 16:00 ET | National Lipid Association
MIAMI, May 17, 2019 (GLOBE NEWSWIRE) -- Findings of the first patient statin use survey based on a comprehensive set of patient experiences and behavioral markers were presented today at the...
NLA LOGO - USE.png
National Lipid Association Releases Official Scientific Statement Regarding Use of Lipoprotein(a) in Clinical Practice
17. Mai 2019 15:45 ET | National Lipid Association
JACKSONVILLE, Fla., May 17, 2019 (GLOBE NEWSWIRE) -- The National Lipid Association (NLA) today announced the release of an official scientific statement on Lipoprotein(a) [Lp(a)] clinical use at...
admera_health_final_logo_transparent_final.jpg
Associates in Cardiovascular Disease and Admera Health Unveiled a Health Economics Model at the 2017 National Lipid Association Conference Detailing the Cost Benefits of Genetic Testing for Familial Hypercholesterolemia
23. Mai 2017 09:25 ET | Admera Health, LLC
SOUTH PLAINFIELD, N.J., May 23, 2017 (GLOBE NEWSWIRE) -- Admera Health, a molecular diagnostics company developing comprehensive genetic tests for risk assessment and early diagnosis of...